Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Пожалуйста, войдите в систему, чтобы принять участие в дискуссии (добавить собственные рецензию, или комментарий)
Цитировать эту публикацию
%0 Journal Article
%1 Butler2024a
%A Butler, Javed
%A Shah, Sanjiv J
%A Petrie, Mark C
%A Borlaug, Barry A
%A Abildstrøm, Steen Z
%A Davies, Melanie J
%A Hovingh, G Kees
%A Kitzman, Dalane W
%A Møller, Daniél Vega
%A Verma, Subodh
%A Einfeldt, Mette Nygaard
%A Lindegaard, Marie L
%A Rasmussen, Søren
%A Abhayaratna, Walter
%A Ahmed, Fozia Z
%A Ben-Gal, Tuvia
%A Chopra, Vijay
%A Ezekowitz, Justin A
%A Fu, Michael
%A Ito, Hiroshi
%A Lelonek, Małgorzata
%A Melenovský, Vojtěch
%A Merkely, Bela
%A Núñez, Julio
%A Perna, Eduardo
%A Schou, Morten
%A Senni, Michele
%A Sharma, Kavita
%A van der Meer, Peter
%A Von Lewinski, Dirk
%A Wolf, Dennis
%A Kosiborod, Mikhail N
%D 2024
%I Elsevier BV
%K HeartFailure efficacy obesity semaglutide
%R 10.1016/s0140-6736(24)00469-0
%T Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
@article{Butler2024a,
added-at = {2024-04-11T09:09:57.000+0200},
author = {Butler, Javed and Shah, Sanjiv J and Petrie, Mark C and Borlaug, Barry A and Abildstrøm, Steen Z and Davies, Melanie J and Hovingh, G Kees and Kitzman, Dalane W and Møller, Daniél Vega and Verma, Subodh and Einfeldt, Mette Nygaard and Lindegaard, Marie L and Rasmussen, Søren and Abhayaratna, Walter and Ahmed, Fozia Z and Ben-Gal, Tuvia and Chopra, Vijay and Ezekowitz, Justin A and Fu, Michael and Ito, Hiroshi and Lelonek, Małgorzata and Melenovský, Vojtěch and Merkely, Bela and Núñez, Julio and Perna, Eduardo and Schou, Morten and Senni, Michele and Sharma, Kavita and van der Meer, Peter and Von Lewinski, Dirk and Wolf, Dennis and Kosiborod, Mikhail N},
biburl = {https://www.bibsonomy.org/bibtex/26ed811b1e3860573110fdc3b33245d1a/jepcastel},
doi = {10.1016/s0140-6736(24)00469-0},
interhash = {ba8b2ccb9a43413adcf0840b961b8754},
intrahash = {6ed811b1e3860573110fdc3b33245d1a},
issn = {0140-6736},
journaltitle = {The Lancet},
keywords = {HeartFailure efficacy obesity semaglutide},
publisher = {Elsevier BV},
timestamp = {2024-04-11T09:09:57.000+0200},
title = {Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials},
year = 2024
}